Patents by Inventor John J. Harrington

John J. Harrington has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20120108399
    Abstract: An apparatus permitting a user to perform a simulated bicycling exercise is provided. The design includes a horizontal base, a lower front pivoting point, and user supporting hardware collectively adjoining pedals, a seat configured to support the user, and handlebars, the user supporting hardware provided above the horizontal base and interfacing with the lower front mounting point. The lower front pivoting point and the user supporting hardware include a multiple component resistive element arrangement and collectively define an axis of rotation forming an angle with the horizontal base of 30 to 45 degrees, sloping upward in a rearward direction from the front pivoting point to the user supporting hardware. When the user is seated on the seat and leans in one direction, such leaning causes the user supporting hardware, seat, and handlebars to rotate in the one direction about the axis of rotation.
    Type: Application
    Filed: January 9, 2012
    Publication date: May 3, 2012
    Applicant: REALRYDER, LLC
    Inventors: Colin Irving, John J. Harrington
  • Patent number: 8092352
    Abstract: An apparatus permitting a user to perform a simulated bicycling exercise is provided. The design includes a frame and a first (lower front) mounting point including a multiple element distributed load arrangement and a second (upper rear) mounting point configured to maintain the frame a first lower front mounting point including a pin defining an axis substantially representing a line joining the second upper rear mounting point and the first lower front mounting point. The design includes a seat, a wheel, and pedals, and the frame is configured to pivot about the axis in response to leaning by the user. Handlebars may be provided that enable force application and enhance the leaning or pivoting in the bicycle riding simulation experience.
    Type: Grant
    Filed: March 3, 2008
    Date of Patent: January 10, 2012
    Assignee: RealRyder, LLC
    Inventors: Colin Irving, John J. Harrington
  • Publication number: 20110217779
    Abstract: The present invention is directed generally to activating gene expression or causing over-expression of a gene by non-homologous or illegitimate recombination, of a regulatory sequence that causes expression of the gene. Thus, by the present invention, endogenous genes, including those associated with human disease and development, may be activated and isolated without prior knowledge of the sequence, structure, function, or expression profile of the genes.
    Type: Application
    Filed: March 1, 2011
    Publication date: September 8, 2011
    Applicant: ABT HOLDING COMPANY
    Inventors: JOHN J. HARRINGTON, BRUCE SCHERF, STEPHEN RUNDLETT
  • Publication number: 20110195820
    Abstract: An apparatus permitting a user to perform a simulated bicycling exercise is provided. The design includes a frame and a first mounting point and a second mounting point configured to maintain the frame. A seat is connected to the frame and configured to support the user. A wheel is positioned in association with said frame and pedals configured to interact with the wheel, and the frame is configured to pivot about the first mounting point and second mounting point in response to leaning by the user. Handlebars may be provided that enable further force application and enhance the leaning or pivoting in the bicycle riding simulation experience.
    Type: Application
    Filed: April 15, 2011
    Publication date: August 11, 2011
    Applicant: RealRyder, LLC.
    Inventors: Colin Irving, John J. Harrington, Brian C. Stewart, Michael S. Lofgren
  • Patent number: 7927258
    Abstract: An apparatus permitting a user to perform a simulated bicycling exercise is provided. The design includes a frame and a first mounting point and a second mounting point configured to maintain the frame. A seat is connected to the frame and configured to support the user. A wheel is positioned in association with said frame and pedals configured to interact with the wheel, and the frame is configured to pivot about the first mounting point and second mounting point in response to leaning by the user. Handlebars may be provided that enable further force application and enhance the leaning or pivoting in the bicycle riding simulation experience.
    Type: Grant
    Filed: August 17, 2007
    Date of Patent: April 19, 2011
    Assignee: Real Ryder, LLC
    Inventors: Colin Irving, John J. Harrington, Brian C. Stewart, Michael S. Lofgren
  • Patent number: 7842792
    Abstract: The present invention is directed generally to activating gene expression or causing over-expression of a gene by recombination methods in situ. The invention also is directed generally to methods for expressing an endogenous gene in a cell at levels higher than those normally found in the cell. In one embodiment of the invention, expression of an endogenous gene is activated or increased following integration into the cell, by non-homologous or illegitimate recombination, of a regulatory sequence that activates expression of the gene. In another embodiment, the expression of the endogenous gene may be further increased by co-integration of one or more amplifiable markers, and selecting for increased copies of the one or more amplifiable markers located on the integrated vector. The invention also provides methods for the identification, activation, isolation, and/or expression of genes undiscoverable by current methods since no target sequence is necessary for integration.
    Type: Grant
    Filed: December 30, 2002
    Date of Patent: November 30, 2010
    Assignee: ABT Holding Company
    Inventors: John J. Harrington, Bruce Sherf, Stephen Rundlett
  • Publication number: 20090285801
    Abstract: The current disclosure provide a novel human calcium sensing receptor named CaR2 and the nucleotide sequence that encodes the receptor. The disclosure further provides antibodies specific for CaR2. Also disclosed are methods of identifying modulators of the receptor and methods of using the identified modulators to treat calcium receptor mediated conditions.
    Type: Application
    Filed: June 11, 2009
    Publication date: November 19, 2009
    Applicant: ABT Holding Company
    Inventors: George Mbella Ekema, Pieter W. Faber, Benjamin Philip Faga, Gregory B. Foust, John J. Harrington, Paul David Jackson, Robert W. Mays
  • Publication number: 20090170667
    Abstract: An apparatus permitting a user to perform a simulated bicycling exercise is provided. The design includes a frame and a first (lower front) mounting point including a multiple element distributed load arrangement and a second (upper rear) mounting point configured to maintain the frame a first lower front mounting point including a pin defining an axis substantially representing a line joining the second upper rear mounting point and the first lower front mounting point. The design includes a seat, a wheel, and pedals, and the frame is configured to pivot about the axis in response to leaning by the user. Handlebars may be provided that enable force application and enhance the leaning or pivoting in the bicycle riding simulation experience.
    Type: Application
    Filed: March 3, 2008
    Publication date: July 2, 2009
    Inventors: Colin Irving, John J. Harrington
  • Publication number: 20090048076
    Abstract: An apparatus permitting a user to perform a simulated bicycling exercise is provided. The design includes a frame and a first mounting point and a second mounting point configured to maintain the frame. A seat is connected to the frame and configured to support the user. A wheel is positioned in association with said frame and pedals configured to interact with the wheel, and the frame is configured to pivot about the first mounting point and second mounting point in response to leaning by the user. Handlebars may be provided that enable further force application and enhance the leaning or pivoting in the bicycle riding simulation experience.
    Type: Application
    Filed: August 17, 2007
    Publication date: February 19, 2009
    Inventors: Colin Irving, John J. Harrington, Brian C. Stewart, Michael S. Lofgren
  • Patent number: 7419828
    Abstract: The present invention is directed generally to activating gene expression or causing over-expression of a gene by recombination methods in situ. The invention also is directed generally to methods for expressing an endogenous gene in a cell at levels higher than those normally found in the cell. In one embodiment of the invention, expression of an endogenous gene is activated or increased following integration into the cell, by non-homologous or illegitimate recombination, of a regulatory sequence that activates expression of the gene. The invention also provides methods for the identification, activation, isolation, and/or expression of genes undiscoverable by current methods since no target sequence is necessary for integration. The invention is specifically directed to methods of drug discovery using the activated gene products for compound testing.
    Type: Grant
    Filed: January 18, 2000
    Date of Patent: September 2, 2008
    Assignee: ABT Holding Company
    Inventor: John J. Harrington
  • Patent number: 7420044
    Abstract: The present invention relates to the identification of novel nucleic acid molecules and the proteins encoded by these nucleic acid molecules, as well as their production for use as therapeutics, diagnostics and for research purposes.
    Type: Grant
    Filed: March 15, 2002
    Date of Patent: September 2, 2008
    Assignee: ABT Holding Company
    Inventors: John J. Harrington, P. David Jackson, Bruce A. Sherf, Scott Cain, Stephen E. Rundlett, Rakesh Ramachandran
  • Patent number: 7316923
    Abstract: The present invention is directed generally to activating gene expression or causing over-expression of a gene by recombination methods in situ. The invention also is directed generally to methods for expressing an endogenous gene in a cell at levels higher than those normally found in the cell. In one embodiment of the invention, expression of an endogenous gene is activated or increased following integration into the cell, by non-homologous or illegitimate recombination, of a regulatory sequence that activates expression of the gene. In another embodiment, the expression of the endogenous gene may be further increased by co-integration of one or more amplifiable markers, and selecting for increased copies of the one or more amplifiable markers located on the integrated vector. In another embodiment, the invention is directed to activation of endogenous genes by non-targeted integration of specialized activation vectors, which are provided by the invention, into the genome of a host cell.
    Type: Grant
    Filed: January 18, 2000
    Date of Patent: January 8, 2008
    Assignee: Athersys, Inc.
    Inventors: John J. Harrington, Bruce Sherf, Stephen Rundlett
  • Patent number: 7033782
    Abstract: The present invention is directed generally to activating gene expression or causing over-expression of a gene by recombination methods in situ. The invention also is directed generally to methods for expressing an endogenous gene in a cell at levels higher than those normally found in the cell. In one embodiment of the invention, expression of an endogenous gene is activated or increased following integration into the cell, by non-homologous or illegitimate recombination, of a regulatory sequence that activates expression of the gene. The invention also provides methods for the identification, activation, isolation, and/or expression of genes undiscoverable by current methods since no target sequence is necessary for integration. Thus, by the present invention, endogenous genes, including those associated with human disease and development, may be activated and isolated without prior knowledge of the sequence, structure, function, or expression profile of the genes.
    Type: Grant
    Filed: January 17, 2001
    Date of Patent: April 25, 2006
    Assignee: Athersys, Inc.
    Inventor: John J. Harrington
  • Patent number: 6965542
    Abstract: A simulated grenade for MILES-type simulations generates a unique RF signal and a unique audio signal. A detector utilizes the time between receipt of the RF signal and the slower-traveling audio signal to determine the distance between the detector and the simulated grenade.
    Type: Grant
    Filed: October 14, 2003
    Date of Patent: November 15, 2005
    Assignee: Sandia Corporation
    Inventors: John J. Harrington, James H. Buttz, Alex B. Maish, Ray R. Page, Herbert E. Metcalf
  • Patent number: 6897066
    Abstract: The field of the invention is activating gene expression or causing over-expression of a gene by recombination methods in situ. The invention relates to expresssing an endogenous gene in a cell at levels higher than those normally found in the cell. Expression of the gene is activated or increased following integration, by non-homolgous or illegitimate recombination, of a regulatory sequence that activates expression of the gene. The method allows the identification and expression of gene undiscovered by current methods since no target sequence is necessary for integration. Thus, gene products associated with human disease and development are obtainable from gene that have not been sequenced and indeed, whose existence is unknown, as well as from well characterized genes. The methods provide gene products from such genes for therapeutic and diagnostic purposes. In one embodiment the vector comprises a promoter, an exon, and an unpaired splice donor sequence, the exon being derived from a eukaryotic gene.
    Type: Grant
    Filed: March 26, 1999
    Date of Patent: May 24, 2005
    Assignee: Athersys, Inc.
    Inventor: John J. Harrington
  • Publication number: 20040162416
    Abstract: The present invention is directed generally to activating gene expression or causing over-expression of a gene by recombination methods in situ. The invention also is directed generally to methods for expressing an endogenous gene in a cell at levels higher than those normally found in the cell. In one embodiment of the invention, expression of an endogenous gene is activated or increased following integration into the cell, by non-homologous or illegitimate recombination, of a regulatory sequence that activates expression of the gene. In another embodiment, the expression of the endogenous gene may be further increased by co-integration of one or more amplifiable markers, and selecting for increased copies of the one or more amplifiable markers located on the integrated vector. In another embodiment, the invention is directed to activation of endogenous genes by non-targeted integration of specialized activation vectors, which are provided by the invention, into the genome of a host cell.
    Type: Application
    Filed: January 17, 2001
    Publication date: August 19, 2004
    Inventors: John J. Harrington, Bruce Sherf, Stephen Rundlett
  • Patent number: 6740503
    Abstract: The present invention is directed generally to activating gene expression or causing over-expression of a gene by recombination methods in situ. The invention also is directed generally to methods for expressing an endogenous gene in a cell at levels higher than those normally found in the cell. In one embodiment of the invention, expression of an endogenous gene is activated or increased following integration into the cell, by non-homologous or illegitimate recombination, of a regulatory sequence that activates expression of the gene. The invention also provides methods for the identification, activation, isolation, and/or expression of genes undiscoverable by current methods since no target sequence is necessary for integration. Thus, by the present invention, endogenous genes, including those associated with human disease and development, may be activated and isolated without prior knowledge of the, sequence, structure, function, or expression profile of the genes.
    Type: Grant
    Filed: January 18, 2000
    Date of Patent: May 25, 2004
    Assignee: Athersys, Inc.
    Inventors: John J. Harrington, Bruce Sherf, Stephen Rundlett
  • Publication number: 20040081970
    Abstract: The current disclosure provide a novel human calcium sensing receptor named CaR2 and the nucleotide sequence that encodes the receptor. The disclosure further provides antibodies specific for CaR2. Also disclosed are methods of identifying modulators of the receptor and methods of using the identified modulators to treat calcium receptor mediated conditions.
    Type: Application
    Filed: October 29, 2002
    Publication date: April 29, 2004
    Applicant: Athersys, Inc.
    Inventors: George Mbella Ekema, Pieter W. Faber, Benjamin Philip Faga, Gregory B. Foust, John J. Harrington, Paul David Jackson, Robert W. Mays
  • Patent number: 6687571
    Abstract: A miniature mobile robot provides a relatively inexpensive mobile robot. A mobile robot for searching an area provides a way for multiple mobile robots in cooperating teams. A robotic system with a team of mobile robots communicating information among each other provides a way to locate a source in cooperation. A mobile robot with a sensor, a communication system, and a processor, provides a way to execute a strategy for searching an area.
    Type: Grant
    Filed: April 24, 2001
    Date of Patent: February 3, 2004
    Assignee: Sandia Corporation
    Inventors: Raymond H. Byrne, John J. Harrington, Steven E. Eskridge, John E. Hurtado
  • Patent number: 6670185
    Abstract: The present invention is directed generally to activating gene expression or causing over-expression of a gene by recombination methods in situ. The invention also is directed generally to methods for expressing an endogenous gene in a cell at levels higher than those normally found in the cell. In one embodiment of the invention, expression of an endogenous gene is activated or increased following integration into the cell, by non-homologous or illegitimate recombination, of a regulatory sequence that activates expression of the gene. The invention also provides methods for the identification, activation, isolation, and/or expression of genes undiscoverable by current methods since no target sequence is necessary for integration. The invention also provides methods for isolation of nucleic acid molecules (particularly cDNA molecules) encoding a variety of proteins.
    Type: Grant
    Filed: January 7, 2000
    Date of Patent: December 30, 2003
    Assignee: Athersys, Inc.
    Inventors: John J. Harrington, Bruce Sherf, Stephen Rundlett